Platform

Search documents
Moomoo Gears Up to Celebrate New York Mets' 50th Victory with a $20,000 Fan Giveaway, Announces 25th Win Prize Recipient with $10,000
Globenewswire· 2025-06-18 13:00
JERSEY CITY, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Moomoo, a global investment and trading platform, is getting ready to celebrate with New York Mets fans with a $20,000 giveaway as the Mets approach the exciting 50th win of the 2025 MLB season. Moomoo also congratulates the Mets on achieving their 25th win by giving $10,000 to the sweepstakes winner - H Smith from Queens, New York. This milestone also activated the first major prize in moomoo’s season-long fan engagement campaign. As part of the strategi ...
国际家居零售(01373) - 2024 H2 - 电话会议演示
2025-06-18 11:23
26 July 2024 2022/23 Annual Results Corporate Presentation International Housewares Retail Company Limited 2023/24 Annual Results 1 Disclaimer Stock code: 1373 This presentation and/or these materials have been delivered to you on the basis of your representation that you are a person into whose possession this presentation and these materials may be lawfully delivered in accordance with all applicable laws of the jurisdiction in which you are located and you may not, nor are you authorized to, deliver this ...
Ascletis Announces First Participants Dosed in U.S. Phase I Clinical Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor for the Treatment of Psoriasis
Prnewswire· 2025-06-18 00:00
Core Insights - Ascletis Pharma Inc. has initiated a Phase I clinical trial for ASC50, an oral small molecule inhibitor targeting interleukin-17 (IL-17), aimed at treating psoriasis [2][3] - The trial is randomized, double-blind, and placebo-controlled, involving both healthy participants and patients with mild-to-moderate plaque psoriasis [3] - Preclinical data suggests that ASC50 has higher oral exposure, a longer half-life, and strong efficacy, positioning it as a potential best-in-class treatment for psoriasis [1] Company Overview - Ascletis Pharma Inc. is a fully integrated biotechnology company focused on developing and commercializing innovative therapeutics for metabolic diseases [4] - The company utilizes its proprietary Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD) Platform and Ultra-Long-Acting Platform (ULAP) to develop drug candidates in-house [4] - Ascletis is listed on the Hong Kong Stock Exchange under the ticker 1672.HK [4]
Amazon Spins Prime Day Into 4-Day Event
PYMNTS.com· 2025-06-17 14:30
Amazon says its annual Prime Day sale is doubling in size this summer.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.The retail giant announced Tuesday (June 17) that the event will stretch over four days instead ...
Qualys Solutions Recognized for Exceptional Performance at SC Awards Europe 2025; Wins in Two Categories
Prnewswire· 2025-06-17 13:00
Qualys TotalCloud wins Best Cloud Security Solution; Qualys VMDR awarded Best Vulnerability Management Solution for third consecutive year FOSTER CITY, Calif., June 17, 2025 /PRNewswire/ -- Qualys, Inc. (NASDAQ: QLYS), a leading provider of disruptive cloud-based IT, security, and compliance solutions, announced wins in two categories at the 2025 SC Awards Europe. Qualys TotalCloud received the top accolade in the Best Cloud Security Solution category, and for the third consecutive year, Qualys Vulnerabilit ...
LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets
Globenewswire· 2025-06-17 13:00
LOUISVILLE, Ky, June 17, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing safety and care economy, announced the appointment of Jeffrey Durkin, as Senior Vice President of Sales effective June 23, 2025. Mr. Durkin previously held sales and marketing roles with InfoMC, Casenet, InstaMed, HMS, and Allscripts. He holds a Master of Business Administration from Anna Maria College and a ...
Roku's Amazon Deal Revenue To Be A 'Gradual Ramp,' Not a Sudden Boost, Analyst Says
Benzinga· 2025-06-16 17:55
JP Morgan analyst Cory A Carpenter maintained an Overweight rating on Roku Inc. ROKU on Monday following the announcement of a strategic partnership with Amazon.com Inc. AMZN.The collaboration allows advertisers to purchase Roku’s advertising inventory through Amazon’s Demand-Side Platform (DSP).Following a call with Roku’s management, JP Morgan has released a note outlining key takeaways from this strategic alliance.Also Read: Roku Stock Surges On New Integration With Amazon: Details Of The DealCarpenter s ...
Kaltura and APTN Bring Indigenous Voices to Screens Across Canada with Streaming Service APTN lumi
Globenewswire· 2025-06-16 15:00
APTN lumi, powered by Kaltura’s end-to-end Cloud TV platform, features the largest collection of Indigenous-language contentNew York, June 16, 2025 (GLOBE NEWSWIRE) -- Kaltura (Nasdaq: KLTR), the AI Video Cloud, today announced that it has partnered with Canadian television network APTN (Aboriginal Peoples Television Network) to power APTN lumi, a streaming service that delivers content to Indigenous communities across Canada and the globe. APTN is dedicated to sharing Indigenous perspectives, stories, a ...
高盛:2025 年 Databricks 数据与人工智能峰会关键要点
Goldman Sachs· 2025-06-15 16:03
12 June 2025 | 11:29AM PDT Americas Technology: Software Key Takeaways from Databricks Data + AI Summit 2025 We attended the Databricks AI + Data Summit 2025 and Investor Briefing on June 10-11 in San Francisco. Reflecting on this alongside our recent participation in the Snowflake Summit, it's increasingly evident that these platforms are becoming central to enterprise AI transformation. Both Databricks and Snowflake are innovating rapidly, with a focus on lowering the barriers to extracting insights from ...
Zoom(ZM) - 2025 FY - Earnings Call Transcript
2025-06-12 18:00
Zoom (ZM) FY 2025 Annual General Meeting June 12, 2025 01:00 PM ET Speaker0 Good morning. I'm Sherene McAlpine, and I'm the chief legal officer of Zoom Communications Inc. I'm very happy to welcome you to Zoom's twenty twenty five annual stockholders meeting. Before we begin, Zoom's founder and CEO and fellow stockholder, Eric Yuan, would like to say a few words. Eric? Speaker1 Thank you, Sri. So good morning, everyone, and welcome. I wanna start by thanking you all, our investors and shareholders, for your ...